{"schema_version":"secwatch.filing_event.v1","accession":"0001185185-22-001454","form_type":"8-K","ticker":"STEX","cik":"0001530766","company_name":"Streamex Corp.","filed_at":"2022-12-28T23:59:59+00:00","discovered_at":"2026-05-14T18:03:51.042503+00:00","generated_at":"2026-06-20T22:26:04.679031+00:00","sec_items":["1.01","3.02","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"BioSig raises ~$1.1M via PIPE of stock and warrants at $0.508/share","bullets":["Sold 2,161,598 shares at $0.508/share and warrants for 1,080,799 shares at $0.4455, raising ~$1.098M.","Warrants exercisable 6 months after closing, expire 5.5 years from issuance date.","Issued Laidlaw warrants for both Nov PIPE (60,976 warrants) and Dec PIPE (49,213 warrants).","Combined November ($1.452M) and December PIPE total ~$2.55M in equity financing."],"urls":{"canonical":"https://secwatch.observer/filing/0001185185-22-001454","json":"https://secwatch.observer/filing/0001185185-22-001454.json","markdown":"https://secwatch.observer/filing/0001185185-22-001454.md","text":"https://secwatch.observer/filing/0001185185-22-001454.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1530766/000118518522001454/0001185185-22-001454-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1530766/000118518522001454/biosig20221227_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-20T22:26:04.679031+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"130aae7376a6a14531d0a06959c17eacab8332c1","claim":"Streamex Corp. entered into Securities Purchase Agreement with certain institutional and accredited investors valued at $1,098,091.79 (effective 2022-12-21).","evidence_excerpt":"On December 21, 2022, BioSig Technologies, Inc. (the “Company”) entered into a Securities Purchase Agreement (the “Purchase Agreement”) with certain institutional and accredited investors (the “Investors”), pursuant to which the Company sold to the Investors an aggregate of 2,161,598 shares (the “Shares”) of the Company’s common stock, par value $0.001 per share (the “Common Stock”) at a purchase price of $0.508 per share, and warrants (the “Warrants”) to purchase up to 1,080,799 shares of Common Stock (the “Warrant Shares” and together with the Shares and Warrants, the “Securities”), at an exercise price of $0.4455 per share, that will become exercisable six months after the date of issuance and will expire five and one-half years following the date of issuance, in exchange for aggregate consideration of $1,098,091.79 (the “December PIPE”).","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1530766/000118518522001454/0001185185-22-001454-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"equity purchase"},{"label":"Counterparty","value":"certain institutional and accredited investors"},{"label":"Value","value":"$1,098,091.79"},{"label":"Effective","value":"2022-12-21"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}